Cargando…
Resistant prolactinoma: Is it monoclonal or polyclonal?
Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas. Multiple pituitary adenomas are reported in less than 1% of pituitary adenomas and rarely result in resistant prolactinoma. We recently encountered an interesting patient of...
Autores principales: | Kumar, K. V. S. Hari, Prusty, Pitambar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830281/ https://www.ncbi.nlm.nih.gov/pubmed/24251135 http://dx.doi.org/10.4103/2230-8210.119534 |
Ejemplares similares
-
Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
por: Mahmood, Iftekhar
Publicado: (2020) -
Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020) -
Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel
por: Nannini, Esteban C., et al.
Publicado: (2015) -
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019) -
Specific Detection of Acanthamoeba species using Polyclonal Peptide Antibody Targeting the Periplasmic Binding Protein of A. castellanii
por: Kim, Min-Jeong, et al.
Publicado: (2022)